BridgeBio Oncology Therapeutics BBOT
NASDAQ BBOT
$3.92 +0.11 (+2.89%)
At close: Sep 29, 2026 · 4:00 PM EDT

BridgeBio Oncology Therapeutics (BBOT) Receivables (2024 - 2026)

Updated

BridgeBio Oncology Therapeutics (BBOT) reported Receivables of $661,000 for Q2 2026, up 352.7% from the prior quarter.

Analysis

BridgeBio Oncology Therapeutics (BBOT) Receivables (2024 - 2026) Analysis & Trends

At the end of FY2025, BridgeBio Oncology Therapeutics posted Receivables of $386,000, up 376.5% from FY2024.

  • By year, Receivables came in at $81,000 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 19.05 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 13.82 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.56 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 9.64 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 15.68 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 10.23 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 5.06 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 12.49 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.13 Bn
10 BridgeBio Oncology Therapeutics 305.24 Mn -1.07 Bn - 661,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 661,000.00
Mar 31, 2026 146,000.00
Dec 31, 2025 386,000.00
Dec 31, 2024 81,000.00
API Access

BridgeBio Oncology Therapeutics Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=BBOT&period=max&api_key=YOUR_API_KEY